Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Glycobiology ; 33(9): 715-731, 2023 10 29.
Article in English | MEDLINE | ID: mdl-37289485

ABSTRACT

Hypercoagulability, a major complication of metastatic cancers, has usually been treated with heparins from natural sources, or with their synthetic derivatives, which are under intense investigation in clinical oncology. However, the use of heparin has been challenging for patients with risk of severe bleeding. While the systemic administration of heparins, in preclinical models, has shown primarily attenuating effects on metastasis, their direct effect on established solid tumors has generated contradictory outcomes. We investigated the direct antitumoral properties of two sulfated fucans isolated from marine echinoderms, FucSulf1 and FucSulf2, which exhibit anticoagulant activity with mild hemorrhagic potential. Unlike heparin, sulfated fucans significantly inhibited tumor cell proliferation (by ~30-50%), and inhibited tumor migration and invasion in vitro. We found that FucSulf1 and FucSulf2 interacted with fibronectin as efficiently as heparin, leading to loss of prostate cancer and melanoma cell spreading. The sulfated fucans increased the endocytosis of ß1 integrin and neuropilin-1 chains, two cell receptors implicated in fibronectin-dependent adhesion. The treatment of cancer cells with both sulfated fucans, but not with heparin, also triggered intracellular focal adhesion kinase (FAK) degradation, with a consequent overall decrease in activated focal adhesion kinase levels. Finally, only sulfated fucans inhibited the growth of B16-F10 melanoma cells implanted in the dermis of syngeneic C57/BL6 mice. FucSulf1 and FucSulf2 arise from this study as candidates for the design of possible alternatives to long-term treatments of cancer patients with heparins, with the advantage of also controlling local growth and invasion of malignant cells.


Subject(s)
Integrin beta1 , Melanoma , Male , Animals , Humans , Mice , Focal Adhesion Protein-Tyrosine Kinases , Integrin beta1/metabolism , Fibronectins/metabolism , Neuropilin-1 , Heparin/pharmacology , Endocytosis
2.
J Comput Biol ; 25(12): 1285-1300, 2018 12.
Article in English | MEDLINE | ID: mdl-30251882

ABSTRACT

In vitro experiments were conducted in this work to analyze the proliferation of tumor (DU-145) and normal (macrophage RAW 264.7) cells under the influence of a chemotherapeutic drug (doxorubicin). Approximate Bayesian Computation (ABC) was used to select among four competing models to represent the number of cells and to estimate the model parameters, based on the experimental data. For one case, the selected model was validated in a replicated experiment, through the solution of a state estimation problem with a particle filter algorithm, thus demonstrating the robustness of the ABC procedure used in this work.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Doxorubicin/pharmacology , Models, Theoretical , Prostatic Neoplasms/pathology , Animals , Cell Line, Tumor , Drug Resistance, Neoplasm , Humans , Male , Mice , RAW 264.7 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...